| AtriCure is a provider of treatments for atrial fibrillation and left atrial appendage management. Co. provides product lines for left atrial appendage management and open and minimally invasive cardiac tissue ablation. Co.'s Radio Frequency Ablation devices include; CryoICE Cryoablation System, which is used in open ablation procedures and consists of the cryoICE Box generator along with a single-use disposable probe; EPi-Sense Guided Coagulation System with VisiTrax Technology, which utilizes monopolar energy for the coagulation of tissue; and LARIAT System, which is a suture-based solution for soft-tissue closure and is compatible with a range of anatomical shapes. We show 42 historical shares outstanding datapoints in our ATRC shares outstanding history coverage, used to compute ATRC market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ATRC market cap history over the course of time is important for investors
interested in comparing ATRC's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ATRC versus a peer is one thing; comparing
ATRC market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ATRC can fluctuate over the course of history.
With this page we aim to empower investors researching ATRC by allowing them to research the ATRC market cap history.